2m 2m 2m 2m 2m 2m 2m
Bristol-MyersSqu (BMY)
NYSE
$55.65+$0.95 (+1.74%)
Price as of Jun 23, 2026 7:09 PM EDT- $111.7BMarket Cap
- 22.41%1-Year Change
- Drug Manufacturers - GeneralIndustry
Bristol-MyersSqu (BMY)
$55.65+$0.95 (+1.74%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 46.8B -3.20% | 48.3B +7.32% | 45.0B -2.50% | 46.2B -0.49% | |
Cost of Revenue | 13.9B -0.23% | 14.0B +30.63% | 10.7B +5.48% | 10.1B +1.98% | |
Gross Profit | 32.8B -4.40% | 34.3B +0.06% | 34.3B -4.74% | 36.0B -1.16% | |
Sales and Marketing Expense | 7.3B -13.63% | 8.4B +8.26% | 7.8B -0.54% | 7.8B +1.61% | |
Research and Development Expense | -10.0B -10.83% | -11.2B +20.00% | -9.3B -2.21% | -9.5B -16.25% | |
Depreciation and Amortization Expense | 4.0B -58.22% | 9.6B -1.64% | 9.8B -5.02% | 10.3B -3.84% | |
Total Operating Expenses | 38.9B -31.43% | 56.7B +55.00% | 36.6B -4.89% | 38.4B +0.42% | |
Operating Profit | 9.3B +211.33% | -8.4B -199.28% | 8.4B +9.43% | 7.7B -4.75% | |
Interest Income | 586.0M +22.59% | 478.0M +6.46% | 449.0M +162.57% | 171.0M +338.46% | |
Interest Expense | N/A N/A | N/A N/A | -1.2B -5.36% | -1.2B -7.65% | |
Interest Income and Expense and Net | 586.0M +22.59% | 478.0M +166.67% | -717.0M -32.42% | -1.1B -18.07% | |
Total Nonoperating Income and Expense | -674.0M -24.52% | -893.0M -177.12% | 1.2B +301.04% | -576.0M -180.00% | |
Income before Taxes | 9.3B +211.33% | -8.4B -199.28% | 8.4B +9.43% | 7.7B -4.75% | |
Income Taxes | 2.3B +310.11% | 554.0M +38.50% | 400.0M -70.76% | 1.4B +26.20% | |
Extraordinary Items | N/A N/A | N/A N/A | 63.0M 0.00% | 63.0M N/A | |
Net Income | 7.1B +178.83% | -8.9B -211.50% | 8.0B +26.84% | 6.3B -9.54% | |
Net Income from Continuing Operations Applicable to Common | 9.3B +211.33% | -8.4B -199.28% | 8.4B +9.43% | 7.7B -4.75% | |
Basic EPS and Net Income | 3.47 +178.68% | -4.41 -213.66% | 3.88 +30.64% | 2.97 -5.71% | |
Diluted EPS and Net Income | 3.46 +178.46% | -4.41 -214.25% | 3.86 +30.85% | 2.95 -5.45% | |
Basic Weighted Average Shares | 2.0B +0.35% | 2.0B -2.03% | 2.1B -2.86% | 2.1B -4.10% | |
Diluted Weighted Average Shares | 2.0B +0.59% | 2.0B -2.45% | 2.1B -3.17% | 2.1B -4.41% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 10.2B -1.32% | 10.3B -9.75% | 11.5B +25.66% | 9.1B -34.74% | |
Short-Term Investments | 464.0M -9.55% | 513.0M -37.13% | 816.0M +527.69% | 130.0M -95.65% | |
Cash and Cash Equivalents and Short-Term Investments | 10.7B -1.71% | 10.9B -11.57% | 12.3B +32.71% | 9.3B -45.46% | |
Total Current Assets | 29.4B -1.31% | 29.8B -6.26% | 31.8B +16.49% | 27.3B -18.01% | |
Accumulated Depreciation | 5.3B +6.95% | 4.9B +3.04% | 4.8B +15.35% | 4.2B +3.25% | |
Property and Plant and Equipment and Net | 7.5B +5.70% | 7.1B +7.37% | 6.6B +6.25% | 6.3B +3.41% | |
Total Long-Term Assets | 6.5B +6.04% | 6.1B +13.69% | 5.4B +8.70% | 4.9B -10.75% | |
Total Assets | 90.0B -2.77% | 92.6B -2.69% | 95.2B -1.72% | 96.8B -11.43% | |
Income Taxes Payable | 222.0M -39.84% | 369.0M +9.17% | 338.0M -84.40% | 2.2B -51.88% | |
Total Short-Term Debt | 2.3B +10.51% | 2.0B -34.40% | 3.1B -26.85% | 4.3B -13.82% | |
Total Current Liabilities | 23.4B -1.50% | 23.8B +6.79% | 22.3B +1.70% | 21.9B +0.10% | |
Total Long-Term Debt | 42.9B -9.98% | 47.6B +29.87% | 36.7B +4.56% | 35.1B -11.49% | |
Total Long-Term Liabilities | 5.0B +12.84% | 4.5B -30.40% | 6.4B -2.56% | 6.6B -10.14% | |
Total Liabilities | 71.5B -6.14% | 76.2B +16.05% | 65.7B -0.04% | 65.7B -10.38% | |
Retained Earnings | 16.9B +13.30% | 14.9B -48.16% | 28.8B +12.79% | 25.5B +7.07% | |
Total Stockholders Equity | 18.5B +13.09% | 16.3B -44.50% | 29.4B -5.25% | 31.1B -13.59% | |
Total Shares Outstanding | 2.9B 0.00% | 2.9B 0.00% | 2.9B 0.00% | 2.9B 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 14.2B -6.81% | 15.2B +9.60% | 13.9B +6.08% | 13.1B -19.38% | |
Capital Expenditures | 1.3B +5.05% | 1.2B +3.23% | 1.2B +8.14% | 1.1B +14.90% | |
Cash from Investing Activities | -4.1B -80.65% | -21.4B +830.37% | -2.3B +116.10% | -1.1B +97.40% | |
Dividends Paid | 5.0B +3.74% | 4.9B +2.51% | 4.7B +2.37% | 4.6B +5.41% | |
Cash from Financing Activities | -10.3B -301.83% | 5.1B +154.45% | -9.4B -44.49% | -17.0B +4.55% | |
Financials Ratio | |||||
Gross Margin | 70.19% -1.25% | 71.08% -6.77% | 76.24% -2.30% | 78.04% -0.68% | |
Operating Margin | 19.95% +215.00% | -17.35% -192.51% | 18.75% +12.23% | 16.71% -4.29% | |
Return on Assets | 7.72% +181.04% | -9.53% -214.01% | 8.36% +36.19% | 6.14% -0.03% | |
Return on Equity | 40.53% +203.65% | -39.10% -247.38% | 26.53% +40.50% | 18.88% -0.41% | |
Revenue Growth | -3.20% -143.68% | 7.32% +393.01% | -2.50% +412.71% | -0.49% -105.36% | |
Current Ratio | 1.26 +0.20% | 1.25 -12.23% | 1.43 +14.54% | 1.25 -18.09% | |
Cash Ratio | 0.44 +0.18% | 0.44 -15.50% | 0.52 +23.56% | 0.42 -34.79% | |
Debt-to-Equity Ratio | 2.44 -19.66% | 3.04 +124.91% | 1.35 +6.75% | 1.27 +2.14% | |
Debt-to-Assets Ratio | 0.50 -6.55% | 0.54 +28.25% | 0.42 +2.93% | 0.41 -0.37% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow